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Abstract
Purpose: Imprecise measurement of physical activity variables might attenuate estimates of the beneficial effects of activity
on health-related outcomes. We aimed to compare the cardiometabolic risk factor dose-response relationships for physical
activity and sedentary behaviour between accelerometer- and questionnaire-based activity measures.
Methods: Physical activity and sedentary behaviour were assessed in 317 adults by 7-day accelerometry and International
Physical Activity Questionnaire (IPAQ). Fasting blood was taken to determine insulin, glucose, triglyceride and total, LDL and
HDL cholesterol concentrations and homeostasis model-estimated insulin resistance (HOMAIR). Waist circumference, BMI,
body fat percentage and blood pressure were also measured.
Results: For both accelerometer-derived sedentary time (,100 counts.min21) and IPAQ-reported sitting time significant
positive (negative for HDL cholesterol) relationships were observed with all measured risk factors – i.e. increased sedentary
behaviour was associated with increased risk (all p#0.01). However, for HOMAIR and insulin the regression coefficients were
.50% lower for the IPAQ-reported compared to the accelerometer-derived measure (p,0.0001 for both interactions). The
relationships for moderate-to-vigorous physical activity (MVPA) and risk factors were less strong than those observed for
sedentary behaviours, but significant negative relationships were observed for both accelerometer and IPAQ MVPA
measures with glucose, and insulin and HOMAIR values (all p,0.05). For accelerometer-derived MVPA only, additional
negative relationships were seen with triglyceride, total cholesterol and LDL cholesterol concentrations, BMI, waist
circumference and percentage body fat, and a positive relationship was evident with HDL cholesterol (p= 0.0002).
Regression coefficients for HOMAIR, insulin and triglyceride were 43–50% lower for the IPAQ-reported compared to the
accelerometer-derived MVPA measure (all p#0.01).
Conclusion: Using the IPAQ to determine sitting time and MVPA reveals some, but not all, relationships between these
activity measures and metabolic and vascular disease risk factors. Using this self-report method to quantify activity can
therefore underestimate the strength of some relationships with risk factors.
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Introduction
There is clear evidence from a large body of epidemiological
data that high levels of physical activity are associated with
reduced risk of a number of adverse health outcomes, including
type 2 diabetes [1], cardiovascular disease [2], and mortality from
any cause [2]. In addition, there is a growing body of evidence that
high levels of sedentary time – usually assessed as time spent sitting
or watching television – are also associated with adverse metabolic
and vascular health outcomes [3–7], and these effects are often
independent of physical activity level.
However, quantification of the strength and nature of the
relationship between physical activity (or sedentary behaviour) and
health outcomes in population-based studies is reliant on accurate
measurement of activity behaviour: poor methods increase
chances of misclassification and can add bias, which can mask
or distort the true underlying relationship between activity and
health [8,9]. Much of the evidence generated in this area – on
which current physical activity guidelines have largely been based
[10,11] – has derived from estimates of physical activity or
sedentary behaviour from self-report questionnaires. Such ques-
tionnaires are easy to administer, inexpensive and do not alter
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behaviour, making them well suited to large-scale investigations
[8,9]. However, activity information derived from self-report is
potentially subject to response bias (e.g. imprecise recall, influence
of social desirability) [12] – and thus validation of activity
questionnaires against criterion measures is vital [13]. One
commonly used physical activity questionnaire is the International
Physical Activity Questionnaire (IPAQ), which, in its long-form,
provides a comprehensive measure of activity in a variety of
contexts (occupational, transport, household, leisure) and intensity
(sitting, moderate, vigorous, walking, cycling) domains [14]. In
validation studies the IPAQ performs at least as well as other self-
report activity measures [13,14]; criterion validity of the long-form
IPAQ (last 7-days) has been assessed, with ‘fair to moderate’
associations being reported between measures of total activity
derived from IPAQ and criterion accelerometer methods (r-values
ranging from 0.05 to 0.55 in different populations) [14,15].
Reported correlations between IPAQ-derived sitting time and
accelerometer-derived sedentary time (,100 counts.min21) have
also been relatively modest (r = 0.14 to 0.51) [14–16].
Imprecise measurement of activity variables can lead to a
diminution of the apparent effects of activity on health-related
outcomes due to regression dilution bias [17]. It is therefore
conceivable that the apparent effects of physical activity and
sedentary behaviour on risk for metabolic and vascular disease are
attenuated when the activity variables are assessed using relatively
imprecise self-report questionnaires, compared to when activity is
assessed by objective techniques such as accelerometry. This has
potentially important implications for the determination of the
precise dose-response relationships between activity and health
benefits, with associated implications for recommendations for the
amounts and types of physical activity needed for optimal health.
Thus, additional validation to quantify the magnitude of this
potential error with questionnaire-based physical activity or
sedentary time assessment is important. A recent study, using
the NHANES database, has compared the relationship between
self-reported and accelerometer-measured moderate-to-vigorous
activity (MVPA) on health-related biomarkers, reporting stronger
associations for the objective activity measures [18]. However, the
self-report questionnaire used in NHANES has not been as
extensively validated as the IPAQ [19], and there have been no
published data comparing the strength of relationship between
self-reported and objectively assessed sedentary behaviour and
metabolic and vascular disease risk factors.
The aim of the present study was therefore to determine
whether the strength of relationships for physical activity and
sedentary behaviour with risk factors for metabolic and vascular
disease differed between measures obtained from IPAQ vs
objective accelerometer in a population of adults with a wide
range of physical activity levels living in rural and urban settings.
Methods
Ethics statement
All participants gave written informed consent prior to inclusion
in this study, which was approved by Research Ethics Committees
at the University of Glasgow, University of Chile, and University
of Concepcio´n.
Participants
Participants were 317 adults (140 men, 177 women), aged 18–
73 years drawn from a wider study investigating the effects of
environment and ethnicity on metabolic risk in the Chilean
population [20]. Of these, 163 were of European ethnic origin and
154 were of Mapuche origin (an Amerindian group native to
Chile); 163 participants lived an urban environment and 154 lived
rurally. Their characteristics are shown in Table 1. Individuals
with a known history of cardiovascular disease or taking anti-
hypertensive or diabetes medications were excluded from partic-
ipation.
Measurement of physical activity by accelerometer
Participants wore accelerometers (ActiTrainer, ActiGraph,
LLC, Pensacola, FL, USA) on the left hip at all times, except
when showering, swimming and sleeping, for seven consecutive
days to objectively assess physical activity levels. Accelerometer
readings were summarized in 60-second epochs and Freedson cut-
points used to define intensity domains (light ,1952 count.min21;
moderate 1952–5724 count.min21; vigorous .5725 count.min21)
[21]. Data from participants with at least 10 hours of daily
accelerometer wear time for 4 days were included in the analysis.
Non-wear was defined by intervals of at least 60 minutes of zero
activity counts [22]. Wear time was calculated by subtracting non-
wear time from 24 hours. Activity count values of ,100
count.min21 were defined as sedentary behaviour [23]. Activity
was reported as minutes per day of sedentary time, moderate
activity and vigorous activity and as MET-minutes (where 1 MET
is equivalent to resting energy expenditure) of moderate-to-
vigorous physical activity (minutes of moderate activity64.0
METs+minutes of vigorous activity68.0 METs). These specific
MET values within the moderate (3.0–6.0 METs) and vigorous
(.6.0 METs) intensity ranges were chosen for consistency with the
MET values assigned for moderate and vigorous activity in the
IPAQ scoring protocol (see below).
Measurement of physical activity by IPAQ
Physical activity and sitting time were measured using a Spanish
language long-form, last 7-day, self-administered version IPAQ,
which was completed immediately following their 7 days of
accelerometer wear [14]. This version of the IPAQ asks questions
about the amount of walking undertaken and participation in
moderate and vigorous activities in work, transportation, domestic
and garden, and leisure domains, amount of cycling undertaken
for transport, and time spent sitting on weekdays and weekend
days, over the preceding 7 days [14]. Data were analyzed in
Table 1. Characteristics of participants.
Variable Mean ± SD Range
Age (y) 37.5612.8 (18–73)
Sex (men/women) 140/177
Glucose (mmol.l21) 5.5261.17 (2.75–11.74)
Insulin (mU.ml21) 6.87612.37 (0.63–78.49)
HOMAIR 2.0962.88 (0.12–18.78)
Total Cholesterol (mmol.l21) 4.7561.21 (2.61–9.77)
HDL cholesterol (mmol.l21) 0.9260.38 (0.38–2.31)
LDL cholesterol (mmol.l21) 3.2761.29 (0.77–8.03)
Triglyceride (mmol.l21) 1.2460.61 (0.18–3.34)
Systolic BP (mm Hg) 123.2616.7 (83–181)
Diastolic BP (mm Hg) 76.6612.4 (39–118)
Body Mass Index (m.kg22) 29.265.1 (18.4–49.3)
Waist Circumference (cm) 102.3613.7 (74.5–136.0)
Body Fat (%) 30.365.9 (14.4–47.5)
doi:10.1371/journal.pone.0036345.t001
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accordance with the IPAQ scoring protocol (https://sites.google.
com/site/theipaq/scoring-protocol). Although walking is a mod-
erate intensity activity by MET value, the IPAQ questionnaire
includes walking as a separate activity domain from moderate
activity, explicitly excluding walking in the moderate activity
questions. Thus, to provide a comparable index to the acceler-
ometer-derived moderate activity measure, the walking and
moderate activity domains from the IPAQ were combined into
a single ‘moderate’ activity domain for analysis. However, in line
with the IPAQ scoring protocol, walking was assigned an intensity
of 3.3 METs, with all other moderate activity assigned an intensity
of 4.0 METs. Thus, IPAQ data are reported as minutes per day of
sitting, moderate activity (including walking) and vigorous activity
and as MET-minutes of MVPA (minutes of walking63.3
METS+minutes of moderate activity (excluding walking)64.0
METS+minutes of vigorous activity68.0 METS). Transport
cycling activity was not included in analyses, but this is unlikely
to substantially influence the study findings as only 13% of the
study population reported any cycling for transport and mean
reported cycling activity was only 5.0 minutes per day in this
cohort.
Physical, biochemical and demographic measurements
Height, body mass, waist and hip circumferences and skinfolds
at four sites (biceps, triceps, subscapular, suprailiac) were measured
using standard protocols [24]. Body composition was calculated
from skinfold measures [25]. Blood pressure was measured on the
right arm after at least 10 minutes of seated rest using an
automated blood pressure monitor (Omron HEM705 CP, Omron
Healthcare UK Limited, Milton Keynes, UK) which has been
validated according to the European Society of Hypertension
International Protocol [26]. The mean of two blood pressure
readings was used in analysis.
Venous blood samples were drawn after an overnight fast and
collected into potassium EDTA tubes and placed on ice. Plasma
was separated within 10 minutes of collection and frozen at
220uC until analysis. Glucose, triglyceride (TG), total cholesterol
and HDL cholesterol, were determined by enzymatic colorimetric
methods using commercially available kits (Roche Diagnostics
Gmbh, Mannheim, Germany; Randox Laboratories Ltd., Co.
Antrim, Ireland; and Kamiya Biomedical, Seattle, USA). LDL
cholesterol was calculated using the Friedewald equation [27].
Insulin concentrations were determined by radioimmunoassay
(Diagnostic System Labs, TX, USA). Coefficients of variation were
,3.0% for all enzymatic colorimetric assays, 5.0% for insulin.
Socioeconomic status was determined with the European
Society for Opinion and Marketing Research (ESOMAR)
questionnaire validated in the Chilean population [28]. The
original 6 ESOMAR socioeconomic classes were re-grouped into
three classes by combining the two lower, two middle and two
higher classes for analysis. Demographic and cultural data (age,
attained education, most recent occupation, and ethnicity) were
determined using the Chilean Socioeconomic Characterisation
Questionnaire [29]. All questionnaire data were collected during
in-person interviews.
Data analysis
Data were analysed using STATA (version 11; Statacorp, TX,
USA). Accelerometer- and IPAQ-derived values for time or MET-
minutes in the different intensity domains were compared by
paired t-test, and the bias and variability between the two
measurement methods for each intensity domain was determined
using a limits of agreement approach [30]. The relationships
between accelerometer-derived and IPAQ-reported activity mea-
sures were assessed using Pearson correlations (r) and concordance
correlation coefficients (Pc). The latter correlation adjusts the r-
value using a bias correction factor, which measures how far the
best-fit line deviates from the line y = x. Pc therefore provides a
composite measure of correlation and agreement between the two
measures.
The relationships between activity variables and risk factor
levels for the accelerometer-derived and IPAQ reported activity
measures were determined in two ways. Firstly, to determine the
strength of relationships between activity variables and risk factor
levels, b values for the unit change in each risk factor with unit (or
unit multiple) change in each accelerometer-derived or IPAQ-
reported measure of activity were calculated using general linear
regression models, adjusted for age, sex, ethnicity, environment
(rural or urban), socio-economic status and smoking. To determine
whether the strength of relationships differed between the
accelerometer and IPAQ activity measures, the analyses were
repeated with the equivalent accelerometer and IPAQ measures
both included in the same model (adjusted for the same
confounders as above) and the interaction between the acceler-
Table 2. Accelerometer-derived and IPAQ-estimates indices of physical activity and sedentary behaviour.
Accelerometer-derived vs
IPAQ-reported activity
measure Accelerometer IPAQ
Difference [IPAQ minus
accelerometer] pb r (95% CI) Pc (95% CI)
(Mean ± SD) (Mean ± SD)
(Mean (Limits of
Agreement))
Sedentary vs. Sitting (min.day21) 523.1690.9 454.26103.1 268.8 (2228.3 to 90.8) ,0.0001 0.654 (0.570 to
0.738)
0.519 (0.402 to
0.697)
Moderate vs. Moderatea (min.day21) 33.7623.7 88.5663.1 54.8 (255.7 to 165.3) ,0.0001 0.458 (0.359 to
0.556)
0.182 (0.103 to
0.291)
Vigorous vs. Vigorous (min.day21) 2.664.8 10.469.4 7.8 (210.7 to 26.4) ,0.0001 0.259 (0.146 to
0.360)
0.134 (0.092 to
0.339)
MVPA vs. MVPAa (MET.min.day21) 155.96117.9 397.86248.3 241.9 (2177.6 to 661.5) ,0.0001 0.508 (0.412 to
0.603)
0.222 (0.126 to
0.367)
N= 317,
amoderate and MVPA domains for IPAQ include walking.
bp-value for comparison between accelerometer and IPAQ mean values.
Limits of Agreement expressed as the mean difference between methods 61.966SD. r = Pearson correlation coefficient; Pc = concordance correlation coefficient.
doi:10.1371/journal.pone.0036345.t002
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ometer- vs IPAQ-derived regression lines was assessed. This, in
effect, assesses whether the b values for the effects of accelerometer
and IPAQ measures on risk factors differed significantly.
Secondly, to determine whether IPAQ-reported and acceler-
ometer-derived activity measures would similarly detect trends for
differences in risk factors across the population distribution of
physical activity and sedentary time, participants were divided into
quartiles for accelerometer-derived MVPA and sedentary time
and for IPAQ-reported MVPA and sitting time. General Linear
Models were used to determine effects of increasing MVPA or
sedentary/sitting time quartile (included in the model as an ordinal
variable) on each risk factor, in models adjusted for age, ethnicity,
sex, environment (rural or urban), socio-economic status and
smoking status. Models for MVPA were then further adjusted for
sitting time (for IPAQ) or sedentary time (for accelerometer) and
models for sitting/sedentary time were adjusted for MVPA. To
determine whether the relationships between MVPA or seden-
tary/sitting time quartile and risk factors differed between the
accelerometer and IPAQ activity measures, the analyses were
repeated with the equivalent accelerometer and IPAQ measures
for MVPA or sedentary/sitting time both included in the same
model (adjusted for the same confounders as above) and the
interaction between the accelerometer-derived vs IPAQ-reported
relationships were assessed.
Statistical significance was accepted at p,0.05.
Results
Agreement and correlation between accelerometer-
derived and IPAQ-reported activity measures
Participants had a wide range of physical activity and sedentary
behaviour levels (Table 2, Figure 1). Mean IPAQ-reported sitting
time was ,13% lower than accelerometer-derived sedentary time
(p,0.0001). Both the Pearson and concordance correlation
coefficients between these two indices of sedentary behaviour
were reasonably strong (Figure 1). In contrast, agreement between
accelerometer-derived and IPAQ-reported measures of physical
activity behaviour was much poorer. IPAQ-reported estimates of
moderate activity, vigorous activity and MVPA were 2.6-, 4.0- and
2.6-fold higher, respectively, than the corresponding accelerom-
eter-derived measures of these indices (all p,0.0001). Pearson
correlations between accelerometer-derived and IPAQ-reported
indices of moderate activity and of MVPA were reasonably strong,
but the Pearson correlation between the two vigorous activity
measures was modest (Table 2). Concordance correlation coeffi-
cients for moderate activity, vigorous activity and MVPA were all
weak (Pc#0.22), reflecting the large divergence of the regression
lines for these correlations from the line of equality (Figure 1
illustrates these data for MVPA).
Table 3 shows the ranges for each quartile of sitting/sedentary
time (in min.day21) and MVPA (in MET.min.day21) for
accelerometer-derived and IPAQ-reported activity measures.
Notably, there was no overlap in quartile threshold values for
accelerometer-derived and IPAQ-reported MVPA: the threshold
for the highest quartile (quartile 4) for accelerometer-derived
MVPA fell within the range of the lowest quartile (quartile 1) for
IPAQ-reported MVPA.
Strength of relationships between IPAQ-reported and
accelerometer-derived activity measures and metabolic
and vascular disease risk factors
Table 4 shows b coefficients for the change in metabolic and
vascular risk factor levels per 100-minute change in accelerometer-
derived sedentary or IPAQ-reported sitting time. Figure 2 provides
a graphical representation of the sitting/sedentary time vs risk
factor relationship for the accelerometer-derived and IPAQ-
reported measures, using triglyceride concentration as an illustra-
tive example of the data presented in Table 4. Data and regression
lines presented in Figure 2 are for unadjusted data, but b
coefficients in Table 4 were adjusted as described in the data
analysis section above. For both accelerometer-derived and IPAQ-
reported measures, significant positive (negative for HDL choles-
terol) b coefficients were observed for all risk factors; in other
words increases in sedentary or sitting time were associated with
increases in risk factor (or decreases in protective factor) level. For
both insulin concentration and HOMAIR there were significant
interactions between the linear regression lines for accelerometer-
derived vs IPAQ-reported relationships: b coefficients were 54%
and 67% larger, for insulin and HOMAIR respectively, for the
accelerometer-derived compared to IPAQ-reported measure of
sedentary behaviour (p for both interactions ,0.0001). The b
coefficients did not differ significantly between accelerometer-
derived vs IPAQ-reported sitting/sedentary time measures for any
other risk factor.
Table 5 presents the same data for accelerometer-derived and
IPAQ-reported measures of MVPA. Figure 2 shows the MVPA vs
triglyceride concentration relationships for accelerometer-derived
and IPAQ-reported measures. For the accelerometer-derived
Figure 1. Relationships between accelerometer-derived seden-
tary time and IPAQ-reported sitting time (top panel) and
between accelerometer-derived and IPAQ-reported MVPA
(bottom panel). Solid line on each plot represents the linear
regression line; dotted line represents the line of equality, y = x. Pearson
(r) and concordance (Pc) correlation coefficients shown.
doi:10.1371/journal.pone.0036345.g001
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measure of MVPA, significant negative b coefficients (positive for
HDL cholesterol) were evident for all risk factor measures except
blood pressure, demonstrating that increasing MVPA was
associated with reductions in metabolic and vascular risk.
However, for the IPAQ-reported measure of MVPA, significant
negative b coefficients were only evident for HOMAIR, glucose
and insulin concentrations. There were significant interactions
between the linear regression lines for accelerometer-derived vs
IPAQ-reported MVPA relationships for insulin concentration,
triglyceride concentration and HOMAIR, with b coefficients being
43%, 50% and 50% greater for the accelerometer-derived
compared to IPAQ-reported MVPA measures, respectively. The
b coefficients did not differ significantly between accelerometer-
derived vs IPAQ-reported MVPA measures for any other risk
factor.
Trends in metabolic and vascular disease risk factors
across quartiles for IPAQ-reported and accelerometer-
derived measures
Table 6 shows risk factor levels for each quartile of accelerom-
eter-derived sedentary time or IPAQ-reported sitting time. As an
illustrative example, the data for triglyceride concentrations by
quartile of sitting/sedentary time for the accelerometer and IPAQ
measures are shown in Figure 3. When the data were analysed in
this manner, significant trends to increase risk factor values with
increasing time spent in sedentary behaviours were observed for
insulin, HOMAIR, triglyceride, BMI and body fat, for both
accelerometer-derived and IPAQ-reported measures. A significant
negative trend for HDL with increasing sedentary behaviour was
evident for both measures. For total and LDL cholesterol, systolic
blood pressure and waist circumference significant trends were
observed for accelerometer-derived but not IPAQ-reported
measures; in other words increases in objectively measured
sedentary behaviours but not sitting time were associated with
increases in these risk factor levels. No significant trends were
found for glucose or diastolic blood pressure for either the
accelerometer-derived and IPAQ-reported measures of sedentary
behaviour. Further adjustment for MVPA in the models did not
alter the significance of any of these findings. There were no
significant interactions between the accelerometer-derived seden-
tary time and IPAQ-reported sitting time vs risk factor trends for
any risk factor.
Table 7 presents the same data for accelerometer-derived and
IPAQ-reported measures of MVPA. Data for triglyceride concen-
tration by quartile of MVPA for the accelerometer and IPAQ
measures are also shown in Figure 3. For the accelerometer-
derived measure of MVPA, significant negative trends in risk
factor levels with increasing MVPA were evident for insulin,
HOMAIR, triglyceride, systolic blood pressure and percentage
body fat and a positive trend was observed for HDL cholesterol. In
other words, increasing MVPA was associated with reductions in
metabolic and vascular risk. However, after adjusting the model
for sedentary time, only the trends for insulin and HOMAIR
remained statistically significant.
In contrast, for the IPAQ-reported data, significant negative
trends in risk factor levels with increasing MVPA were only
evident for insulin and HOMAIR concentrations. A borderline
(p=0.055) trend towards a decrease in total cholesterol with
increasing MVPA was also observed. After adjusting the model for
sitting time, the trend to decrease cholesterol with increasing
MVPA became statistically significant, but the significant trends
for insulin and HOMAIR were lost. To determine whether
including walking in the IPAQ-reported MVPA measure influ-
Table 3. Quartile ranges for accelerometer-derived and IPAQ-estimates indices of physical activity and sedentary behaviour.
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Sitting/sedentary time (min.day21) Accelerometer ,447 447–523 524–578 .578
IPAQ ,365 365–450 451–535 .535
MVPA (MET.min.day21) Accelerometer ,76 76–125 126–201 .201
IPAQ ,233 233–325 326–484 .484
doi:10.1371/journal.pone.0036345.t003
Figure 2. Relationships between sedentary/sitting time and
triglyceride concentration (top panel) and MVPA and triglyc-
eride concentration (bottom panel) for accelerometer-derived
and IPAQ-reported activity measures. Solid line on each plot
represents the linear regression line for accelerometer-derived activity
measure; dotted line is the regression line for IPAQ-reported activity
measure. Unadjusted data values presented. See Tables 4 and 5 for b
coefficients and p-values for regression lines, adjusted for age, sex,
ethnicity, environment and socio-economic status and smoking.
doi:10.1371/journal.pone.0036345.g002
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enced these dose-response relationships, the analyses were
repeated excluding walking from the IPAQ MVPA measure –
i.e. defining MVPA as: minutes of moderate activity (excluding
walking)64.0 METS+minutes of vigorous activity68.0 METS.
This analysis yielded essentially identical results. No significant
interactions were observed between the accelerometer-derived and
IPAQ-reported MVPA vs risk factor trends for any risk factor.
Discussion
The main findings of this study were: 1) Compared to objective,
accelerometer-derived measures, using the IPAQ to determine
activity measures led to significant over-reporting of physical
activity and under-reporting of sedentary behaviour. The concor-
dance correlation coefficient for accelerometer-derived vs IPAQ-
reported activity measures was reasonably strong for sedentary
behaviour (Pc = 0.52, p,0.0001), but much weaker for indices of
Table 4. Regression coefficients (b) for relationships between Actigraph-derived sedentary time and IPAQ-reported sitting time
and vascular and metabolic risk factors.
Outcome Sedentary Time – Accelerometer Sitting Time – IPAQ
b (95%CI) p-value b (95%CI) p-value p-interaction
Glucose (mmol.l21) 0.2 (0.08 to 0.4) 0.003 0.1 (0.01 to 0.002) 0.008 0.936
Insulin (mU.l21) 6.8 (5.1 to 8.4) ,0.0001 4.4 (3.0 to 5.8) ,0.0001 ,0.0001
HOMAIR 1.5 (1.2 to 1.8) ,0.0001 0.9 (0.7 to 1.3) ,0.0001 ,0.0001
Total Cholesterol (mmol.l21) 0.31 (0.14 to 0.46) ,0.0001 0.21 (0.10 to 0.34) 0.002 0.943
HDL cholesterol (mmol.l21) 20.13 (20.18 to 20.08) ,0.0001 20.11 (20.15 to 20.06) ,0.0001 0.794
LDL cholesterol (mmol.l21) 0.36 (0.18 to 0.52) ,0.0001 0.27 (0.13 to 0.42) ,0.0001 0.910
Triglyceride (mmol.l21) 0.17 (0.09 to 0.25) ,0.0001 0.09 (0.02 to 0.16) 0.009 0.564
Systolic BP (mm Hg) 2.9 (0.8 to 5.0) 0.006 2.2 (0.5 to 4.0) 0.012 0.445
Diastolic BP (mm Hg) 2.1 (0.4 to 3.7) 0.012 1.8 (0.4 to 3.2) 0.009 0.100
Body Mass Index (m.kg22) 1.4 (0.8 to 2.1) ,0.0001 0.7 (0.2 to 1.3) 0.005 0.796
Waist Circumference (cm) 3.1 (1.3 to 4.9) 0.001 1.5 (0.02 to 3.0) 0.046 0.547
Body Fat (%) 1.8 (1.1 to 0.025) ,0.0001 0.6 (0.06 to 1.2) 0.030 0.475
N= 317. Data presented as b coefficient and 95%CI for change in risk factor per 100-minute change in sedentary/sitting time, adjusted for age, sex, ethnicity,
environment and socio-economic status and smoking. P-values values are given for b values for each measurement method and for the interaction between regression
coefficients derived from accelerometer vs IPAQ measurements.
doi:10.1371/journal.pone.0036345.t004
Table 5. Regression coefficients (b) for relationships between Actigraph-derived and IPAQ-reported MVPA and vascular and
metabolic risk factors.
Outcome MVPA – Accelerometer MVPA – IPAQ
b (95%CI) p b (95%CI) p p-interaction
Glucose (mmol.l21) 20.08 (20.2 to 20.04) 0.021 20.1 (20.2 to 20.01) 0.037 0.305
Insulin (mU.l21) 22.8 (24.2 to 21.4) ,0.0001 21.9 (23.4 to 20.5) 0.010 0.002
HOMAIR 20.6 (20.8 to 0.3) ,0.0001 20.4 (20.7 to 20.2) 0.002 ,0.0001
Total Cholesterol (mmol.l21) 20.11 (20.23 to 20.02) 0.011 20.06 (20.19 to 20.07) 0.388 0.102
HDL cholesterol (mmol.l21) 0.07 (0.03 to 0.11) 0.001 0.02 (20.21 to 0.07) 0.311 0.261
LDL cholesterol (mmol.l21) 20.14 (20.27 to 20.01) 0.042 20.06 (20.20 to 0.08) 0.403 0.181
Triglyceride (mmol.l21) 20.07 (20.13 to 20.02) 0.035 20.04 (20.11 to 0.02) 0.188 0.011
Systolic BP (mm Hg) 21.4 (23.1 to 0.1) 0.070 21.6 (23.2 to 0.04) 0.056 0.084
Diastolic BP (mm Hg) 20.1 (21.3 to 1.1) 0.887 0.1 (21.2 to 1.4) 0.870 0.061
Body Mass Index (m.kg22) 20.2 (20.7 to 20.1) 0.023 20.3 (20.8 to 0.2) 0.188 0.448
Waist Circumference (cm) 20.6 (22.0 to 20.7) 0.036 21.1 (22.5 to 0.3) 0.130 0.258
Body Fat (%) 21.5 (21.6 to 20.5) ,0.0001 20.5 (21.1 to 0.01) 0.055 0.138
N= 317. Data presented as b coefficient and 95%CI for change in risk factor per 100-MET.min change in MVPA, adjusted for age, sex, ethnicity, environment and socio-
economic status and smoking. P-values values are given for b values for each measurement method and for the interaction between regression coefficients derived
from accelerometer vs IPAQ measurements.
doi:10.1371/journal.pone.0036345.t005
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physical activity (Pc#0.22 for all measures), indicating that the
IPAQ quantified sedentary behaviour more accurately than it
quantified physical activity. 2) For some metabolic and vascular
disease risk factors, significant trends were observed between
amount of sedentary behaviour or MVPA and the risk factor when
activity was assessed by IPAQ. However, for other risk factors
significant trends with amount of sedentary behaviour or MVPA
were only apparent when activity was assessed objectively by
accelerometer. In addition, significant interactions were observed
for some risk factors (insulin, triglyceride and HOMAIR) in the
gradient of the activity vs risk factor regression lines for
accelerometer-derived compared to IPAQ-reported activity mea-
sures. These data suggest that, compared to the use of objective
accelerometry, using the IPAQ to estimate physical activity and
sedentary behaviour may result in failure to detect real relation-
ships with metabolic and vascular disease risk factors or in
underestimation of the strength of those relationships. 3)
Irrespective of the activity measurement method, time spent
engaging in sedentary behaviour was more robustly associated
with the cardio-metabolic risk profile than time spent undertaking
MVPA.
The IPAQ systematically overestimated vigorous activity by
,8 minutes per day (4-fold), and, when walking was included in
the moderate activity domain, overestimated moderate activity by
55 minutes per day – a 2.6-fold difference. However, agreement
between accelerometer- and IPAQ-derived indices of sedentary
behaviour was somewhat better with a mean difference of
69 minutes per day (,13%), despite the measures not being
directly equivalent (i.e. time spent sitting down vs time at ,100
accelerometer counts.min21). These data suggest that while
reports of absolute amounts of physical activity determined by
the IPAQ questionnaire should be viewed with caution – a minute
of IPAQ-reported physical activity is not equivalent to a minute of
accelerometer-derived activity – questionnaire-derived estimates of
sedentary time agree reasonably well with the objective measure.
The Pearson correlations observed between IPAQ-reported and
accelerometer-derived indices of physical activity in the present
study were in line with, or slightly higher than, previous reports in
the literature [14–16], indicating that the IPAQ performed at least
Table 6. Vascular and metabolic risk factor values by quartile of accelerometer-derived sedentary time and IPAQ-reported sitting
time.
Risk Factor
Activity Measurement
Method
Quartile 1
(n =79)
Quartile 2
(n=79)
Quartile 3
(n =79)
Quartile 4
(n =80) p-trend* p-trend#
Glucose (mmol.l21) Accelerometer 5.3460.12 5.4560.13 5.5260.12 5.7760.13 0.200 0.358
IPAQ 5.4460.13 5.3360.12 5.4660.14 5.8460.12 0.058 0.054
Insulin (mU.l21) Accelerometer 2.8261.22 6.1061.26 9.1161.22 15.961.29 0.0001 0.0001
IPAQ 3.7861.23 5.7661.16 9.5661.33 14.9261.24 0.0001 0.0001
HOMAIR Accelerometer 0.7060.27 1.5260.28 2.2160.27 4.0560.28 0.0001 0.0001
IPAQ 0.9460.27 1.4160.25 2.3260.29 3.8160.27 0.0001 0.0001
Total Cholesterol
(mmol.l21)
Accelerometer 4.4160.13 4.6060.14 4.9960.13 5.0260.13 0.004 0.019
IPAQ 4.5560.13 4.6960.12 4.8160.14 4.9760.13 0.381 0.322
HDL cholesterol
(mmol.l21)
Accelerometer 1.0760.04 1.0160.04 0.8360.04 0.7460.04 0.0001 0.0001
IPAQ 1.1060.04 0.9460.03 0.8260.04 0.7860.04 0.0001 0.0001
LDL cholesterol
(mmol.l21)
Accelerometer 2.8960.13 3.0460.14 3.5360.13 3.6360.14 0.0009 0.005
IPAQ 2.9860.14 3.1960.13 3.3860.15 3.5660.14 0.125 0.115
Triglyceride (mmol.l21) Accelerometer 0.9860.06 1.2060.06 1.3460.06 1.4160.07 0.0001 0.002
IPAQ 1.0360.06 1.2160.06 1.3360.07 1.3760.06 0.014 0.013
Systolic BP (mm Hg) Accelerometer 120.761.6 120.261.5 126.361.6 126.061.6 0.013 0.044
IPAQ 121.261.6 121.561.5 124.661.7 126.161.6 0.187 0.191
Diastolic BP (mm Hg) Accelerometer 74.361.29 74.961.28 78.361.32 78.561.31 0.069 0.088
IPAQ 74.761.30 75.661.22 78.661.36 77.461.29 0.285 0.278
Body Mass Index
(kg.m22)
Accelerometer 27.560.51 28.560.51 30.260.53 30.660.52 0.0001 0.0003
IPAQ 27.760.52 29.360.48 29.660.54 30.260.51 0.047 0.049
Waist circumference
(cm)
Accelerometer 98.861.46 100.161.45 104.161.49 106.361.48 0.003 0.003
IPAQ 98.461.47 102.561.38 104.361.54 104.161.46 0.066 0.065
Body Fat (%) Accelerometer 28.560.58 29.460.57 30.860.59 32.660.59 0.0001 0.007
IPAQ 28.760.58 30.160.54 31.560.61 31.360.58 0.018 0.019
Values are means 6 SEM for each quartile.
*Model adjusted for age, ethnicity, sex, environment, socio-economic status and smoking status.
#Model adjusted for age, ethnicity, sex, environment, socio-economic status, smoking status and MVPA.
doi:10.1371/journal.pone.0036345.t006
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as well in our hands as for others. Thus, the relative differences in
the magnitude of dose-response relationships with risk factors
between IPAQ-reported and accelerometer-derived activity mea-
sures observed in the present study are likely to be broadly
transferable to populations beyond that used in the present study.
In the analysis reported here, the relationships between activity
variables and risk factor levels were determined in two different
ways. Firstly, b-coefficients for the change in risk factor level per
unit change in sedentary behaviour or MVPA were calculated for
the IPAQ-reported and accelerometer-determined activity mea-
sures. This provides a measure of the unit change in risk factor per
100 minute change in sedentary behaviour or per 100 MET.-
min21 change (equivalent to 25 minutes of moderate activity) in
MVPA. This approach revealed significant relationships between
sedentary behaviour and all of the measured risk factors,
irrespective of whether sedentary behaviour was assessed by
IPAQ or accelerometer. However, the b-coefficients for insulin
and HOMAIR were over 50% larger when sedentary behaviour
was determined objectively by accelerometer, indicating that using
the IPAQ for activity assessment leads to a significant underes-
timation of the steepness of the dose-response relationship between
sedentary behaviour and metabolic risk factors related to insulin
resistance. The IPAQ also performed less well for MVPA than it
did for sitting time in revealing significant associations with risk
factors that were evident when activity was objectively measured.
The IPAQ missed significant trends for MVPA that were evident
for the accelerometer for total, LDL and HDL cholesterol,
triglyceride, BMI, waist circumference and body fat, with only
significant trends for glucose, insulin and HOMAIR being
detected. Furthermore, the b-coefficients for insulin, triglyceride
and HOMAIR were significantly lower for the IPAQ-reported
compared to accelerometer-derived MVPA measures. These
findings are in broad agreement with the NHANES report which
found that the relationships of MVPA with a large number of risk
factors were less strong when activity was assessed by question-
naire rather than accelerometer [18]. The present findings extend
the NHANES data by presenting data for sedentary behaviour as
well as MVPA.
In a separate analysis, the trends for activity measures with risk
factors were presented in terms of change in risk factor per quartile
change in MVPA or sedentary behaviour within the population,
rather than change in risk factor by change in sedentary behaviour
or MVPA in terms of absolute units (i.e. per min.day21 or per
MET.min21.day21). This approach, in effect, adjusts for any
systematic bias in reporting from the questionnaires. For example,
the mean reported MET.min.day21 value for MVPA for IPAQ
was 2.6 times the accelerometer-derived MVPA measure, but a
consistent 2.6 fold over-reporting of MVPA with the IPAQ
compared to the accelerometer measure would have no effect on
the population distribution into quartiles of MVPA. Using this
approach, the present data revealed that the trends for changes in
MVPA/sedentary behaviour across the population distribution
with a wide range of vascular and metabolic risk factors were
broadly similar – there were no significant interactions with
measurement method in the activity vs risk factor relationships for
any risk factor – but not all of the significant trends identified when
activity was objectively quantified were observed with the IPAQ.
This suggests that imprecision of measurement of activity – i.e.
regression dilution bias – when using the IPAQ reduced the ability
to detect significant trends with some risk factors, but the overall
pattern of the activity vs risk factor trends were similar for both
measurement approaches. Thus, the relative imprecision of
activity measurement by IPAQ could potentially be overcome
by studying larger cohorts, but accelerometers offer the advantage
of detecting significant trends with risk factors in smaller numbers
of individuals, when activity variables are expressed in terms of
position in the population distribution. However, while this
analytical approach is useful in determining general trends
between activity and risk factors, it does have the clear limitations
of being unable of providing absolute activity values to quantify
the dose-response relationships, as well as having less statistical
power than when activity behaviour is considered as a continuous
variable.
The observation that the dose-response relationship between
activity measures and some risk factors is quantitatively different
between self-reported and objectively measured activity is an
important consideration when formulating guidelines for physical
activity. Current physical activity guidelines, which were largely
based on evidence from self-report activity measures, recommend
that adults undertake 150 minutes of moderate intensity physical
activity or 60–75 minutes of vigorous activity per week to maintain
and improve health [10,11]. The present findings suggest that the
amounts of activity required for good health are likely to be lower
for objectively measured (compared to reported) activity, an issue
which has been alluded to by others [18,22,31]. Indeed,
accelerometer-derived measures of physical activity are consis-
tently lower than values obtained from self-reported data [22].
Figure 3. Triglyceride concentrations by quartile of sitting/
sedentary time (top panel) or MVPA (bottom panel) for the
accelerometer-derived and IPAQ-reported activity measures.
Trends for triglyceride concentration by sitting/sedentary time quartile
significant for both accelerometer (p=0.0001) and IPAQ (p= 0.014)
measures. Trends for triglyceride concentration by MVPA quartile
significant for the accelerometer (p = 0.022), but not the IPAQ
(p=0.139), activity measure.
doi:10.1371/journal.pone.0036345.g003
Objective vs. Self-Reported Physical Activity
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36345
Thus, it is important that objective activity monitoring methods
are used in the epidemiological studies to determine the optimal
activity levels for guidelines as well as in surveillance of activity
levels within the population. Using objective measures to assess
compliance with guidelines that were based on evidence from self-
reported activity, risks providing an inaccurate picture of the
proportion of the population who are insufficiently active, which
can have important implications with respect to formulation of
physical activity policy.
It is of interest that sedentary behaviour was more consistently
associated with vascular and metabolic risk factor levels than
MVPA was. The difference was most evident for the IPAQ-
reported activity measures (12 vs 3 significant b-coefficients with
risk factors for sitting time vs MVPA), so may reflect in part the fact
that the IPAQ quantifies sedentary behaviour more accurately
than MVPA. However, the effect was still evident, albeit to a lesser
extent, for accelerometer-derived measures (12 vs 10 significant b-
coefficients). Furthermore, adjusting the sedentary behaviour vs
risk factor trends for MVPA did not alter the strength of
association. A number of significant trends for MVPA vs risk
factor were lost after adjustment for sedentary behaviour, even for
accelerometer-derived activity measures, suggesting that this is a
real biological effect and not simply a consequence of measure-
ment error. This observation is in agreement with other published
data revealing a larger effect of sedentary behaviour than physical
activity on a number of vascular and metabolic risk factors [3,32],
although this is not an unequivocal finding [33]. Nevertheless, the
present findings add to the growing literature highlighting the
important influence of sedentary behaviour on indices of vascular
and metabolic health.
A particular strength of this study is that the study population
was diverse. Participants were men and women, with a wide range
of educational and socioeconomic backgrounds and spanned a
wide range of activity levels. Mean activity levels in the present
cohort were higher than in NHANES, which represented a
nationally representative sample for the US, and half the cohort
lived in rural settings. Our findings were robust to adjustment for
age, sex, ethnicity, environment and socio-economic status, and
thus should be generalisable across a wide demographic range and
particularly to populations outside the US where physical activity
Table 7. Vascular and metabolic risk factors values by quartile of accelerometer-derived and IPAQ-reported time spent in MVPA.
Risk Factor
Activity
Measurement
Method
Quartile 1
(n=79)
Quartile 2
(n =79)
Quartile 3
(n=79)
Quartile 4
(n =80) p-trend* p-trend#
Glucose (mmol.l21) Accelerometer 5.5860.12 5.6660.12 5.4660.12 5.3560.13 0.348 0.723
IPAQ 5.6360.16 5.6760.10 5.4160.12 5.3060.13 0.153 0.164
Insulin (mU.l21) Accelerometer 14.9361.27 6.8761.25 6.8261.27 4.2661.32 0.0001 0.0005
IPAQ 13.7961.62 7.6361.06 6.8361.28 7.0861.36 0.015 0.215
HOMAIR Accelerometer 3.6760.29 1.8160.28 1.6860.28 1.0560.29 0.0001 0.0002
IPAQ 3.5160.36 1.9560.24 1.6760.28 1.6960.31 0.002 0.093
Total Cholesterol
(mmol.l21)
Accelerometer 4.8860.13 4.8860.13 4.6060.13 4.6260.13 0.288 0.818
IPAQ 4.6860.16 4.9860.11 4.7060.13 4.4960.14 0.055 0.047
HDL cholesterol
(mmol.l21)
Accelerometer 0.8260.04 0.8960.04 0.9560.04 1.0260.04 0.012 0.757
IPAQ 0.8960.05 0.8960.03 0.9060.04 0.9960.04 0.413 0.505
LDL cholesterol
(mmol.l21)
Accelerometer 3.4560.14 3.4060.14 3.1160.14 3.1160.14 0.218 0.847
IPAQ 3.2460.18 3.4960.11 3.2260.14 2.9960.15 0.092 0.085
Triglyceride (mmol.l21) Accelerometer 1.3460.06 1.3060.06 1.1960.06 1.0760.06 0.022 0.586
IPAQ 1.2060.08 1.3160.05 1.2660.06 1.0960.07 0.139 0.128
Systolic BP (mm Hg) Accelerometer 126.861.6 123.161.5 119.661.6 123.561.6 0.019 0.064
IPAQ 124.261.9 124.261.4 122.261.5 122.361.6 0.707 0.709
Diastolic BP (mm Hg) Accelerometer 78.661.2 75.561.2 74.561.3 77.161.3 0.134 0.168
IPAQ 77.961.5 76.961.1 75.361.2 76.161.3 0.626 0.609
Body Mass Index
(kg.m22)
Accelerometer 29.560.53 29.560.52 29.460.53 28.560.53 0.486 0.723
IPAQ 29.460.64 29.260.47 29.260.52 29.160.54 0.993 0.994
Waist Circumference
(cm)
Accelerometer 102.461.4 103.161.4 103.661.4 100.161.5 0.349 0.332
IPAQ 105.261.7 100.561.3 101.961.4 102.761.5 0.199 0.195
Body Fat (%) Accelerometer 31.860.58 30.960.57 30.160.59 28.460.59 0.0006 0.083
IPAQ 30.960.71 30.760.52 30.360.58 29.560.60 0.588 0.590
Values are means 6 SEM for each quartile.
*Model adjusted for age, ethnicity, sex, environment, socio-economic status and smoking status.
#Model adjusted for age, ethnicity, sex, environment, socio-economic status, smoking status and sedentary/sitting time.
doi:10.1371/journal.pone.0036345.t007
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levels may be higher. This is also the first study to compare the
effects of objective vs subjective measurements of sedentary time
on the dose-response relationship with vascular and metabolic risk
factors. However, while we showed good agreement between the
accelerometer-derived and IPAQ-reported sedentary time mea-
sures, it is important to recognise the ,100 accelerometer counts
per minute is not exactly the same as time spent sitting down, as
the former measure can also include standing and some very low
intensity upright activities (such as swaying). It has been suggested
that contractions in postural muscles elicited by standing may
confer some metabolic benefit compared to sitting [34], thus the
potential inclusion of standing activities in our accelerometer-
derived sedentary behaviour measure could conceivably have
attenuated the apparent risk factor dose-response relationships.
Further study, using inclinometers, comparing the risk factor dose-
response relationships for objectively- and questionnaire-assessed
sitting time is needed to address this issue.
In conclusion, the findings of this study indicate that using
IPAQ to determine physical activity or sitting time reveals a
number of significant trends with metabolic and vascular disease
risk factors. However, the IPAQ missed some significant trends
that were evident when activity was objectively assessed, partic-
ularly for MVPA, and led to underestimation of the strength of
some relationships between activity and risk factors. Thus, a
degree of caution is advised when using activity measurements
obtained from the IPAQ to quantify dose-response relationships
for activity and risk factors for metabolic and vascular disease.
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